XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net loss $ (53,675,000) $ (99,929,000) $ (167,887,000)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation and amortization 21,208,000 24,942,000 27,492,000
Non-cash operating lease costs 16,268,000 15,329,000 19,155,000
Stock-based compensation 135,862,000 45,017,000 12,044,000
Deferred income taxes (85,579,000) (18,929,000) (77,860,000)
Amortization of intangible assets and acquired technology 188,825,000 245,895,000 287,767,000
Amortization of debt issuance costs 3,607,000 5,380,000 6,074,000
Amortization of investment discount, net of premium (1,002,000) 0 0
Loss on debt refinancing 0 30,882,000 37,400,000
Unrealized loss (gain) on remeasurement of debt 0 (29,711,000) 50,552,000
Changes in operating assets and liabilities:      
Accounts receivable (17,249,000) (26,350,000) (8,487,000)
Prepaid expenses and other assets (25,511,000) (64,177,000) (42,550,000)
Accounts payable and accrued liabilities (50,697,000) 36,799,000 (11,204,000)
Income taxes payable 12,127,000 (19,766,000) 22,733,000
Contract liabilities 55,873,000 83,301,000 12,525,000
Net cash provided by operating activities 200,057,000 228,683,000 167,754,000
Investing activities:      
Purchases of property and equipment (5,465,000) (10,817,000) (13,835,000)
Purchases of investments (290,040,000) (90,357,000) (36,842,000)
Maturities of investments 109,548,000 68,761,000 19,605,000
Business acquisitions, net of cash acquired 0 0 (21,439,000)
Net cash used in investing activities (185,957,000) (32,413,000) (52,511,000)
Financing activities:      
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs 0 905,852,000 0
Proceeds from issuance of common stock under employee stock purchase plan 32,790,000 0 0
Payments of offering costs (2,085,000) 0 0
Payments for dividends related to Class B-2 shares (24,000) 0 0
Payments for share repurchases 0 (9,318,000) (3,286,000)
Payment of debt (14,063,000) (1,373,592,000) (825,981,000)
Payment of debt issuance costs 0 (25,545,000) (32,211,000)
Proceeds from issuance of debt 0 441,318,000 949,965,000
Payment for settlement of vested stock options 0 0 (7,506,000)
Payments for taxes related to net share settlement of equity awards 0 (2,825,000) (2,356,000)
Payment of contingent consideration 0 (10,705,000) (6,180,000)
Net activity from derivatives with an other-than-insignificant financing element 2,236,000 (18,978,000) (5,555,000)
Proceeds from issuance of shares upon exercise of options 19,947,000 7,426,000 3,400,000
Net cash provided by / (used in) financing activities 38,801,000 (86,367,000) 70,290,000
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash (13,118,000) (28,000) (13,703,000)
Net increase in cash, cash equivalents, and restricted cash 39,783,000 109,875,000 171,830,000
Cash, cash equivalents, and restricted cash at beginning of period 458,096,000 348,221,000 176,391,000
Cash, cash equivalents, and restricted cash at end of period 497,879,000 458,096,000 348,221,000
Supplemental disclosures:      
Cash paid for interest 84,563,000 103,243,000 143,833,000
Cash paid for income taxes, net of refunds 92,930,000 65,260,000 32,635,000
Non-cash investing and financing activities:      
Purchases of property and equipment recorded in accounts payable and accrued liabilities 1,390,000 693,000 793,000
Deferred offering costs payable or accrued but not paid $ 0 $ 2,086,000 $ 0